Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: A hospital-based case-control study

Thrombosis Research

Volumn 120, Issue 2, 2007, Pages 207-214

  Oger, Emmanuel ^a   Lacut, Karine ^a   Le Gal, Grégoire ^a   Couturaud, Francis ^a   Abalain, Jean Hervé ^a   Mercier, Bernard ^a   Mottier, Dominique ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENE MUTATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FACTOR V; FEMALE; FRANCE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; POINT MUTATION; PREGNANCY; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; VARIATION (GENETICS); VENOUS THROMBOSIS;

EID: 34248577160     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.10.002     Document Type: Article

References (22)

1. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBO Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 83 (2000) 657-660
2. Rosendaal F.R. Venous thrombosis: a multicausal disease. Lancet 353 (1999) 1167-1173
3. Dahlback B., Carlsson M., and Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90 (1993) 1004-1008
4. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
5. Koster T., Rosendaal F.R., de Ronde H., Briet E., Vandenbroucke J.P., and Bertina R.M. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia study. Lancet 342 (1993) 1503-1506
6. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
7. Mudd S.H., Skovby F., Levy H.L., Pettigrew K.D., Wilcken B., Pyeritz R.E., et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37 (1985) 1-31
8. Mandel H., Brenner B., Berant M., Rosenberg N., Lanir N., Jakobs C., et al. Coexistence of hereditary homocystinuria and factor V Leiden: effect on thrombosis. N Engl J Med 334 (1996) 763-768
9. den Heijer M., Lewington S., and Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3 (2005) 292-299
10. Ridker P.M., Hennekens C.H., Selhub J., Miletich J.P., Malinow M.R., and Stampfer M.J. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95 (1997) 1777-1782
11. de Stefano V., Zappacosta B., Persichilli S., Rossi E., Casorelli I., Paciaroni K., et al. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br J Haematol 106 (1999) 564-568
12. Tsai A.W., Cushman M., Tsai M.Y., Heckbert S.R., Rosamond W.D., Aleksic N., et al. Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: longitudinal investigation of thromboembolism etiology (LITE). Am J Hematol 72 (2003) 192-200
13. Keijzer M.B., den Heijer M., Blom H.J., Bos G.M., Willems H.P., Gerrits W.B., et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 88 (2002) 723-728
14. Eichinger S., Stumpflen A., Hirschl M., Bialonczyk C., Herkner K., Stain M., et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 80 (1998) 566-569
15. den Heijer M., Koster T., Blom H.J., Bos G.M., Briet E., Reitsma P.H., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334 (1996) 759-762
16. Quere I., Lamarti H., and Chadefaux-Vekemans B. Thrombophilia, homocystinuria, and mutation of the factor V gene. N Engl J Med 335 (1996) 289
17. Kluijtmans L.A., Boers G.H., Verbruggen B., Trijbels F.J., Novakova I.R., and Blom H.J. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis. Blood 91 (1998) 2015-2018
18. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263 (1990) 2753-2759
19. Leroyer C., Mercier B., Escoffre M., Ferec C., and Mottier D. Factor V Leiden prevalence in venous thromboembolism patients. Chest 111 (1997) 1603-1606
20. Leroyer C., Mercier B., Oger E., Chenu E., Abgrall J.F., Ferec C., et al. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients. Thromb Haemost 80 (1998) 49-51
21. Rodgers G.M., and Kane W.H. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77 (1986) 1909-1916
22. Lentz S.R., and Sadler J.E. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88 (1991) 1906-1914